title: Sodium phosphate tablets and acute phosphate nephropathy.
authors: Office of Surveillance and Epidemiology, Food and Drug Administration, Building 22, Room 3472, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, USA. ann.mackey@fda.hhs.gov
authors: Ann Corken
authors: AC
authors: Mackey
authors: Lanh
authors: L
authors: Green
authors: Keith St
authors: KS
authors: Amand
authors: Mark
authors: M
authors: Avigan
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D002400:Cathartics / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000009:adverse effects / Q000378:metabolism*; D013607:Tablets
chemical_list: D002400:Cathartics; D010710:Phosphates; D013607:Tablets; C018279:sodium phosphate